Zwitterionic nanoparticles for thermally activated drug delivery in hyperthermia cancer treatment.

ABSTRACT: Hyperthermia is considered a promising strategy to boost the curative outcome of traditional chemotherapeutic treatments. However, this thermally mediated drug delivery is still affected by important limitations. First, the poor accumulation of the conventional anticancer formulations in the target site limits the bioavailability of the active ingredient and induces off-site effects. In addition, some tumoral scenarios, such as ovarian carcinoma, are characterized by cell thermotolerance, which induces tumoral cells to activate self-protecting mechanisms against high temperatures. To overcome these constraints, we developed thermoresponsive nanoparticles (NPs) with an upper critical solution temperature (UCST) to intracellularly deliver a therapeutic payload and release it on demand throug

SUBMITTER: Colli C 

PROVIDER: S-EPMC11223588 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature